Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at :

NCT ID NCT05393791
Title Phase II Randomised Controlled Trial of Patient-specific Adaptive vs. Continuous Abiraterone or eNZalutamide in mCRPC (ANZadapt)
Acronym ANZadapt
Recruitment Recruiting
Gender male
Phase Phase II
Variant Requirements No
Sponsors Leiden University Medical Center
Age Groups: senior | adult
Covered Countries NLD | AUS

Facility Status City State Zip Country Details
Border Medical Oncology Research Unit / The Border Cancer Hospital RECRUITING Albury New South Wales 2460 Australia Details
Chris O'Brien Lifehouse NOT_YET_RECRUITING Camperdown New South Wales 2050 Australia Details
Calvary Mater Newcastle RECRUITING Newcastle New South Wales 2298 Australia Details
Genesis Care North Shore RECRUITING St Leonards New South Wales 2065 Australia Details
Sydney Adventist Hospital NOT_YET_RECRUITING Wahroonga New South Wales 2076 Australia Details
Mater Hospital Brisbane RECRUITING South Brisbane Queensland 4101 Australia Details
Royal Adelaide Hospital RECRUITING Adelaide South Australia 5000 Australia Details
Fiona Stanly Hospital RECRUITING Murdoch Western Australia 6150 Australia Details
Radboud Univeristy Medical Centre RECRUITING Nijmegen Gelderland 6525 GA Netherlands Details
Spaarne Gasthuis NOT_YET_RECRUITING Hoofddorp Noord-Holland 2134 TM Netherlands Details
Isala Ziekenhuis NOT_YET_RECRUITING Zwolle Overijssel 8025 AB Netherlands Details
Meander Medical Centre RECRUITING Amersfoort Utrecht 3813 TZ Netherlands Details
Groene Hart Ziekenhuis NOT_YET_RECRUITING Gouda Zuid-Holland 2803 HH Netherlands Details
Leids Universitair Medisch Centrum RECRUITING Leiden Zuid-Holland 2333 ZA Netherlands Details
University Medical Center Groningen NOT_YET_RECRUITING Groningen 9713 GZ Netherlands Details
*Shaded cells indicate that there was no data available from for the field